These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28152324)

  • 1. Efficacy of repeated low-dose bevacizumab treatment with long-dosing interval for radiation-induced brain necrosis: A case report.
    Meng X; Zhao R; Wu S; Shen G; Ding L; Sun B; Wang J
    Cancer Biol Ther; 2017 Jan; 18(1):63-66. PubMed ID: 28152324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
    Ma Y; Zheng C; Feng Y; Xu Q
    J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
    Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
    J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-shot bevacizumab for cerebral radiation injury.
    Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
    BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases.
    Hu Q; Zhao J; Xu J; Zhou X; Shui Y; Shen L; Wei Q
    Oncol Res Treat; 2017; 40(3):133-137. PubMed ID: 28231593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
    Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
    Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of radiation-induced myelopathy with bevacizumab.
    Cañedo G; Solis I; González-San Segundo C; Madero L; Lassaletta A
    Clin Transl Oncol; 2020 Jun; 22(6):957-960. PubMed ID: 31571152
    [No Abstract]   [Full Text] [Related]  

  • 9. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues.
    Zhuang H; Shi S; Yuan Z; Chang JY
    Mol Cancer; 2019 Feb; 18(1):21. PubMed ID: 30732625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose bevacizumab for radiation-induced brain necrosis: a case report.
    Panagiotou E; Charpidou A; Fyta E; Nikolaidou V; Stournara L; Syrigos A; Gkiozos I
    CNS Oncol; 2023 Sep; 12(3):CNS98. PubMed ID: 37140173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
    Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
    Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bevacizumab on radiation necrosis of the brain.
    Gonzalez J; Kumar AJ; Conrad CA; Levin VA
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of Bevacizumab for Cerebral Radiation Necrosis.
    Zhuang H; Yuan X; Yuan Z; Wang P
    Recent Pat Anticancer Drug Discov; 2017; 12(3):272-277. PubMed ID: 28443515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
    Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of cerebral radiation necrosis by bevacizumab.
    Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
    J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
    Bodensohn R; Hadi I; Fleischmann DF; Corradini S; Thon N; Rauch J; Belka C; Niyazi M
    Strahlenther Onkol; 2020 Jan; 196(1):70-76. PubMed ID: 31586230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis.
    Zhuang H; Yuan X; Zheng Y; Li X; Chang JY; Wang J; Wang X; Yuan Z; Wang P
    Sci Rep; 2016 Apr; 6():24364. PubMed ID: 27067388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
    Lubelski D; Abdullah KG; Weil RJ; Marko NF
    J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
    Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
    J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.